Kenneth A Iczkowski
Overview
Explore the profile of Kenneth A Iczkowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
2231
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fernandez Gonzalez De La Vega C, Duenweg S, Jain P, Rubenstein S, Bobholz S, Barrett M, et al.
Pathol Res Pract
. 2024 Mar;
256:155239.
PMID: 38461692
Background: Vasculature plays a crucial role in the progression of prostate cancer (PC). Changes to the prostatic native vessels have not been studied since 2000 when Garcia et al. demonstrated...
12.
Maranto C, Sabharwal L, Udhane V, Pitzen S, McCluskey B, Qi S, et al.
Sci Adv
. 2024 Feb;
10(9):eadi2742.
PMID: 38416822
Androgen receptor (AR) drives prostate cancer (PC) growth and progression, and targeting AR signaling is the mainstay of pharmacological therapies for PC. Resistance develops relatively fast as a result of...
13.
Nguyen N, Liu K, Lajkosz K, Iczkowski K, van der Kwast T, Downes M
J Clin Pathol
. 2024 Feb;
PMID: 38378247
Aims: Pre-surgical risk classification tools for prostate cancer have shown better patient stratification with the addition of cribriform pattern 4 (CC) and intraductal prostatic carcinoma (IDC) identified in biopsies. Here,...
14.
Karan D, Wick J, Dubey S, Kumar-Sinha C, Siddiqui J, Kunju L, et al.
Cancer
. 2023 Dec;
130(4):647-648.
PMID: 38079361
No abstract available.
15.
Duenweg S, Brehler M, Lowman A, Bobholz S, Kyereme F, Winiarz A, et al.
Lab Invest
. 2023 Oct;
103(12):100269.
PMID: 37898290
Prostate cancer is the most commonly diagnosed cancer in men, accounting for 27% of the new male cancer diagnoses in 2022. If organ-confined, removal of the prostate through radical prostatectomy...
16.
Duenweg S, Bobholz S, Barrett M, Lowman A, Winiarz A, Nath B, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760407
Prostate cancer (PCa) is the most diagnosed non-cutaneous cancer in men. Despite therapies such as radical prostatectomy, which is considered curative, distant metastases may form, resulting in biochemical recurrence (BCR)....
17.
Lopez-Beltran A, Raspollini M, Hansel D, Comperat E, Williamson S, Liedberg F, et al.
Am J Surg Pathol
. 2023 Sep;
48(1):e24-e31.
PMID: 37737692
Emerging data on T1 bladder cancer subcategorization (aka substaging) suggests a correlation with oncological outcomes. The International Society of Urological Pathology (ISUP) organized the 2022 consensus conference in Basel, Switzerland...
18.
Karan D, Wick J, Dubey S, Kumar-Sinha C, Siddiqui J, Kunju L, et al.
Cancer
. 2023 Sep;
129(23):3783-3789.
PMID: 37698493
Background: This study aimed to understand the differential levels of inflammatory chemokines in association with higher prostate cancer incidence and mortality in African American (AA) men than in Caucasians (CA)....
19.
Downes M, Liu K, Yu Y, Lajkosz K, Kroon L, Hollemans E, et al.
Clin Genitourin Cancer
. 2023 Aug;
22(1):47-55.
PMID: 37558528
Background: Pretreatment stratification tools can help in clinical decision making in prostate cancer. To date, none incorporates well-established routinely reported adverse prognostic pathologic features such as intraductal carcinoma of prostate...
20.
Duenweg S, Bobholz S, Lowman A, Stebbins M, Winiarz A, Nath B, et al.
J Pathol Inform
. 2023 Jul;
14:100321.
PMID: 37496560
Purpose: Digital pathology is becoming an increasingly popular area of advancement in both research and clinically. Pathologists are now able to manage and interpret slides digitally, as well as collaborate...